Mobile Contingency Management for Smoking Cessation in Returning US Veterans
1 other identifier
interventional
291
1 country
1
Brief Summary
The primary goal of the study is to evaluate the effectiveness of a combined tele-health and contingency management (CM) intervention that the investigators call mobile CM, or mCM, in promoting smoking abstinence in US Veterans. The mCM intervention will combine a mobile system to reward non-smoking, smoking cessation counseling, and smoking cessation medications. The primary aim is to evaluate how effective this intervention is in promoting smoking abstinence compared to telehealth interventions for smoking cessation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2015
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2015
CompletedFirst Submitted
Initial submission to the registry
July 28, 2015
CompletedFirst Posted
Study publicly available on registry
July 31, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 14, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
February 14, 2019
CompletedFebruary 21, 2020
February 1, 2020
4.1 years
July 28, 2015
February 19, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
smoking, self-report
Participants' self-report of smoking in the past seven days will be measured at 6-month follow-up study visit.
6 month follow-up (6 months post-quit attempt)
Secondary Outcomes (5)
saliva cotinine
6 month follow-up (6 months post-quit attempt)
smoking, self-report
Approx. ten weeks after enrollment (i.e., eight weeks after smoking quit attempt)
saliva cotinine
Approx. ten weeks after enrollment (i.e., eight weeks after smoking quit attempt)
smoking, self-report
3 month follow-up (3 months post-quit attempt)
saliva cotinine
3 month follow-up (3 months post-quit attempt)
Study Arms (2)
Mobile Contingency Management (mCM)
EXPERIMENTALThe mCM arm represents a proactive tele-health intervention that combines guideline based cognitive-behavioral smoking cessation telephone counseling, a tele-medicine clinic for access to nicotine replacement therapy (NRT), and intensive behavioral therapy administered via a smart phone (with carbon monoxide monitor) based application. NRT may include nicotine patches (21 mg, 14 mg, and or 7 mg) used daily for six weeks from the smoking quit date. Dosage will depend on participants' reported smoking patterns and carbon monoxide readings. NRT may also include a "rescue" method, i.e., either nicotine gum or nicotine lozenge. The participants' preferred NRT rescue method will be prescribed and used as needed to reduce smoking craving for six weeks from the smoking quit date.
Tele-Health for Smoking Ccessation
ACTIVE COMPARATORTELE-HEALTH FOR SMOKING CESSATION is a proactive tele-health intervention that will provide controls for therapist, medication, time and attention effects. The tele-health intervention provides the same guideline based cognitive-behavioral smoking cessation telephone counseling, and tele-medicine clinic for access to NRT as in the mCM intervention. NRT may include nicotine patches (21 mg, 14 mg, and or 7 mg) used daily for six weeks from the smoking quit date. Dosage will depend on participants' reported smoking patterns and carbon monoxide readings. NRT may also include a "rescue" method, i.e., either nicotine gum or nicotine lozenge. The participants' preferred NRT rescue method will be prescribed and used as needed to reduce smoking craving for six weeks from the smoking quit date.
Interventions
Participants will be prescribed one form of nicotine replacement "rescue" treatment (i.e., gum, lozenge), and may choose nicotine gum as the preferred "rescue" treatment. Participants will be instructed to use the rescue method as needed during the post-quit phase of the study to reduce cigarette cravings.
Participants will be asked to provide video recordings of themselves taking carbon monoxide readings in order to confirm smoking abstinence. Participants are asked to upload these videos to the study's secured server, and are provided reinforcement for videos that suggest smoking abstinence.
Participants receive five sessions of cognitive-behavioral telephone counseling, and a participant manual. The telephone counseling protocol included in this application is based on standard cognitive-behavioral therapy techniques shown to be efficacious for smoking cessation and is informed by behavioral treatment principles .
Participants will be prescribed nicotine patches to be used during the post-quit phase of the study.
Participants will be prescribed one form of nicotine replacement "rescue" treatment (i.e., gum, lozenge), and may choose nicotine lozenge as the preferred "rescue" treatment. Participants will be instructed to use the rescue method as needed during the post-quit phase of the study to reduce cigarette cravings.
Participants in the experimental condition will be loaned a smart phone to use during the mobile contingency management intervention period. The phone will be used to record videos of carbon monoxide readings to determine smoking abstinence.
Participants in the experimental condition will be loaned a CO monitor to use during the mobile contingency management intervention period. The monitor will be used to determine carbon monoxide content in the breath as a measurement of smoking.
Eligibility Criteria
You may qualify if:
- Smoked at least 10 cigarettes on at least 15 of 30 days before screening
- Served during OEF/OIF/OND era
- Are willing to make a smoking cessation attempt
- Enrolled in the Durham VA for ongoing care
- English speaking
You may not qualify if:
- Use and unwillingness to stop use of other forms of nicotine such as cigars, pipes, or chewing tobacco
- Active diagnosis of a primary psychotic disorder per medical record
- Are currently imprisoned or in psychiatric hospitalization
- Severely impaired hearing or speech such that telephone counseling is not possible
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duke Universitylead
- Durham VA Medical Centercollaborator
Study Sites (1)
Duke University Medical Center
Durham, North Carolina, 27706, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Patrick S Calhoun, Ph.D.
Duke University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 28, 2015
First Posted
July 31, 2015
Study Start
January 1, 2015
Primary Completion
February 14, 2019
Study Completion
February 14, 2019
Last Updated
February 21, 2020
Record last verified: 2020-02